Shareholders’ Nomination Board’s proposal for the composition of Aktia Bank Plc’s Board of Directors and their remuneration

Aktia Bank’s Shareholders’ Nomination Board proposes a seven-member board for the 2026 AGM, re-electing Joakim Frimodig, Juha Hammarén, Maria Jerhamre Engström, Hanne Katrama, Harri Lauslahti and Sari Somerkallio, and adding Elina Fogelholm (current CEO of Veritas, ex-Danske/Nordea) subject to Finnish FSA clearance. The nominees have signalled intent to elect Hammarén as Chair and Frimodig as Deputy Chair; Hammarén is not independent due to prior executive roles including CEO through May 2024. Board remuneration is proposed unchanged (Chair EUR75,000; Deputy EUR50,000; member EUR40,000; committee chairs EUR8,000; meeting fees EUR700/€1,400) with approximately 40% of annual pay to be delivered in Aktia shares acquired/transferred after the Q1 2026 interim report.

Analysis

Market structure: The Nomination Board’s proposals are governance-stability signals rather than strategic inflection — winners are incumbent shareholders and institutional holders (Varma, Etola/Veritas) who prefer continuity; losers are activist narratives and short-term traders betting on board shakeups. The 40%-in-shares remuneration creates a predictable, small buy demand (gross board pay ~EUR 40k–75k per member implies buy orders in low tens of thousands EUR) — negligible for liquidity but positive for order flow in a small-cap (market cap implied by EUR 16.3bn AuM / EUR 12.3bn balance sheet suggests AKTIA.HE is sub-mid cap). Cross-asset impact is minimal: credit spreads and FX unaffected absent regulatory action; Nordic bank peers see mild relative sentiment moves.

Risk assessment: Tail risks include the Finnish Financial Supervisory Authority (FIN-FSA) refusing the new appointment or raising fitness-and-probity concerns, which could trigger a 10–20% >1-week drawdown; operational risk if ex-CEO Juha Hammarén chairs (conflict-of-interest issues) could slow strategic decisions. Time horizons: immediate (0–60 days) event risk around FIN-FSA/AGM; short-term (3–6 months) modest upside from share-based alignment and clarity; long-term (12–36 months) depends on capital allocation and asset-management performance. Hidden dependencies: major institutional owners control the Nomination Board — they can prevent hostile changes and influence dividends/capital returns; catalyst watchlist: FIN-FSA comments, AGM vote, interim report (1 Jan–31 Mar) publishing window.

Trade implications: Direct play: asymmetric small-cap long in AKTIA.HE sized 1–3% portfolio with tight stops — expected 8–12% upside in 3–6 months if AGM passes and no regulator objections. Pair trade: long AKTIA.HE vs short DANSKE.CO (beta-adjusted) to capture idiosyncratic governance rerating while hedging macro bank risk; size short to 30–50% notional of long. Options: buy 3-month ATM call or call spread on AKTIA.HE to cap downside capital and leverage upside; buy protective 3-month puts sized to 50% of position if FIN-FSA commentary is negative. Entry: initiate after AGM confirmation or on >5% dip; exit on +8–12% move or at 6 months.

Contrarian angles: Markets underappreciate that 40% share remuneration and institutional Nomination Board composition materially raises stickiness of insider shareholdings — a modest but persistent supply reduction not reflected in price. Consensus may overplay governance risk from an ex-CEO chair; historical Nordic regional bank cases show such appointments cause short-lived discounts (median 6–10% over 2–8 weeks) that rebound once regulator sign-off occurs. Unintended consequence: a FIN-FSA delay could create tradable volatility spikes; prepared options hedges convert that volatility into buying opportunities.

Key Decisions for Investors

• Establish a 1–3% long position in AKTIA.HE within 30 days contingent on no adverse FIN-FSA pre-AGM announcement; target a 8–12% upside over 3–6 months, set stop-loss at -8% or liquidate immediately if FIN-FSA issues a formal objection.
• Buy a 3-month ATM call or 3-month bull call spread on AKTIA.HE equal to 50% of the delta-equivalent long exposure to leverage upside while capping premium; if implied vol >30%, prefer a debit spread to control cost.
• Implement a pair trade: long AKTIA.HE vs short DANSKE.CO sized to 1:0.4 notional (beta-adjusted) to isolate governance/idiosyncratic rerating; close the pair if AKTIA outperforms the short by >5% absolute or after 6 months.
• If FIN-FSA delays or issues negative commentary, buy protective 1–2 month puts on AKTIA.HE sized to 50% of position to hedge tail risk and add to long on >10% intraday dip (scale-in up to additional 1% portfolio).
• Reallocate 1–2% portfolio weight from large Nordic insurers/banks (e.g., SAMPO.HE) into AKTIA.HE post-AGM confirmation to capitalize on small-cap governance re-rating; reverse if AKTIA underperforms peers by >7% over 3 months.